Delivery Order SPE2DB22D1103-SPE2DB24FTRS4
Award Date
9/19/24
Potential Completion Date
9/20/24
Potential Value
$4.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Cosentyx (secukinumab) 300mg dose syringes to the Defense Logistics Agency (DLA). The $11,139.37 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, through the company's Indefinite Delivery Contract (IDC) with the DLA valued at $999,999,999. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Cosentyx (secukinumab) 300 mg dose-2 pens per mL, a specialty pharmaceutical product. The contract was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, and does not have any set-aside designation. The contract is a delivery order with a firm fixed-price of $4,886.77 and an ultimate completion date of September 13, 2024. AmerisourceBergen holds a larger Indefinite...
This federal contract award is for the delivery of Cosentyx (secukinumab) 300mg dose prefilled syringes to the Defense Logistics Agency (DLA), a component of the Department of Defense. The $12,637.98 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 2, 2024. The contract has a completion date of December 3, 2024 and was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This contract award is for the delivery of Cosentyx (secukinumab) 300mg dose injections to the Defense Logistics Agency (DLA), a defense agency. The $6,568.26 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, on December 1, 2023 with a completion date of December 4, 2023. This order is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $3,992.60, is for the delivery of Cosentyx (Secukinumab) 300mg dose injectable medication. This is a firm fixed-price delivery order contract with a completion date of March 13, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award is for the delivery of Cosentyx (Secukinumab) 300mg dose 2-pen injectors to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 6, 2024 with a ceiling value of $5,966.20 and a completion date of February 7, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating open competition....
This federal contract award is for the delivery of Cosentyx (secukinumab) 300mg medication to the Defense Logistics Agency (DLA). The $6,087.80 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 27, 2023 with a completion date of December 28, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for...
This federal contract award, valued at $15,258.91, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Cosentyx (secukinumab) 300mg doses, a specialty medication used to treat certain autoimmune conditions. The contract is a Firm Fixed Price Delivery Order with a completion date of July 18, 2024. There is no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award is for the delivery of the pharmaceutical product Cosentyx (secukinumab) in 300 mg dose prefilled syringes. The contract, valued at $1,521.95, was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). This is a firm fixed-price delivery order under a larger indefinite delivery contract (IDC) between AmerisourceBergen and the DLA, valued up to $999,999,999, for the supply of a comprehensive range of...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation is for the delivery of Cosentyx (secukinumab) 300mg dosage pharmaceutical products. The $1,607 firm-fixed-price delivery order has a completion date of July 18, 2024 and does not utilize a set-aside. AmerisourceBergen is the prime contractor and holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for the company to...